Depomed (DEPO) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development expense: 10.41M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q2 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $116.7 million versus the consensus estimate of $118.2 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- Jack Henry (JKHY) Tops Q4 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
